PDL BioPharma Balance Sheet
View: Annual | Quarterly
| Assets | Dec 08 | Dec 07 | Dec 06 |
|---|---|---|---|
| Current Assets | |||
| Cash | 129.3 | 340.6 | 179.0 |
| Net Receivables | 13.5 | 5.2 | 18.8 |
| Inventories | 0.0 | 0.0 | 19.7 |
| Other Current Assets | 37.9 | 374.6 | 162.0 |
| Total Current Assets | 180.7 | 720.4 | 379.5 |
| Net Fixed Assets | 1.1 | 330.7 | 296.5 |
| Other Noncurrent Assets | 9.3 | 141.0 | 465.9 |
| Total Assets | 191.1 | 1,192.2 | 1,141.9 |
| Liabilities and Shareholder's Equity | Dec 08 | Dec 07 | Dec 06 |
| Current Liabilities | |||
| Accounts Payable | 1.7 | 8.9 | 13.5 |
| Short-Term Debt | 0.0 | 0.7 | 0.6 |
| Other Current Liabilities | 29.8 | 112.5 | 91.3 |
| Total Current Liabilities | 31.5 | 122.1 | 105.5 |
| Long-Term Debt | 500.0 | 534.8 | 500.0 |
| Other Noncurrent Liabilities | 12.2 | 27.6 | 68.9 |
| Total Liabilities | 543.7 | 684.6 | 674.4 |
|
Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | 0.0 |
| Common Stock Equity | (352.6) | 507.6 | 467.5 |
| Total Equity | (352.6) | 507.6 | 467.5 |
| Shares Outstanding (mil.) | 119.5 | 119.5 | 119.5 |
© 2009 Morningstar, Inc. Financial Data provided by
